Searched for
PFIZER Q2
Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...- Millions set to get 80% off prescription drugs as White House rolls out ‘TrumpRx’ planPresident Donald Trump has launched TrumpRx, a direct-to-consumer website created to make prescription medications up to 80% cheaper for Am...
- PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 billion Metsera weight-loss acquisitionPfizer Inc. (NYSE: PFE) experienced a significant uptick in its stock price following two major announcements on September 30, 2025. Presid...
- Pfizer PFE stock, Metsera MTSR stock: Pfizer, Metsera share prices jump as deal worth over $7 billion gets thumbs upStock Market boom for both companies' shares came as Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up t...
- COVID wave is moving across USA: Health experts warn parents that children must do thisCovid symptoms 2025: Public health experts noted that the coronavirus is still a threat, even for otherwise healthy children younger than 2.
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Pfizer Q2 Results: Profit plunges 52% YoY to Rs 149 croreRevenue from operations declined 9.76 per cent to Rs 575.21 crore in the quarter as against Rs 637.47 crore in the year-ago period.
- Pfizer Q2 Results: Profit tumbles 77% to $2.3 billion; co trims 2023 revenue outlookThese include US approval for a drug combination for prostate cancer and a needed recommendation on the Abrysvo vaccine from the US Centers...
- Q4 Results Roundup: How Kalyan Jewellers, Tube Investments, Pfizer India, Karur Vysya Bank faredTube Investments reported a rise of 84% in net profit, reaching Rs 251 crore. Pfizer India saw a marginal increase in net profit to Rs 130 ...
- Pfizer Q2 results: Net profit up 9% to Rs 143 croreRevenue from operations stood at Rs 636.26 crore for the quarter under consideration, as against Rs 595.41 crore a year ago, it added.
- Hold Pfizer, target price Rs 4,665: Anand RathiThe pharma major launched its patented product, Zavicefta, in India in H1 FY20. This was the first anti-infective drug launched by Pfizer i...
- Pfizer Q2 up 61% to Rs 154.25 crorePfizer's total expenses were at Rs 430.63 crore during the period under review as against Rs 407.92 crore, up 5.56 per cent.
- Stocks in the news: YES Bank, TCS, Ashok Leyland, Raymond, Pfizer and IL&FS TransportHere are a few stocks which by buzz the most in today's trade.
- Pfizer Q2 net profit falls 14% to Rs 95.8 croreShares of Pfizer were trading at Rs 2,808 apiece in afternoon trade on BSE.
- Buy Pfizer, target Rs 2900: Centrum BrokingBuy Pfizer Ltd. at a price target of Rs 2900.
- Wyeth Q3 profit dips 32% to Rs 17.46 croreDrug firm Wyeth reported 32.08 per cent dip in standalone profit at Rs 17.46 crore for the third quarter ended December 31, 2013-14 fiscal.
- Pfizer Q2 net profit up 33% at Rs 69.59 crorePfizer today reported 33.11 pc rise in standalone net profit to Rs 69.59 cr for the second quarter ended September 30, 2013-14 fiscal.
- Pfizer posts Q2 net profit at Rs 46.99 croreNet sales of the company stood at Rs 271.82 crore for the quarter ended September 30, 2011. It was Rs 225.61 crore for the quarter ended Au...
- Pfizer Q2 up two fold at Rs 35.89 crGlobal pharmaceutical company, Pfizer Ltd on Wednesday posted an increase of over two fold in net profit after tax at Rs 35.89 crore for th...
Load More
